As an example, identification of de novo mutations in patients linked the FMRP partner candidates Tbl1xr1 and Chd4 to autism spectrum disorders (Coe et al., 2019; O'Roak et al., 2012; Quan et al., 2020). This evidence concerns the gene CHD4 and autism spectrum disorder.